Treatment Patterns and Outcomes of Acthar Gel in Ankylosing Spondylitis and Psoriatic Arthritis: A Physician-Reported Chart Review
Based on chart review, Acthar Gel may represent a potential treatment option for appropriate patients with AS or PsA. In this study, among patients with AS or PsA treated with Acthar Gel, physicians documented a reduction in overall symptoms, decreased pain, improved physical function, reduced corticosteroid use, improved strength, and improved fatigue using prespecified assessments.
Authors
- George J. Wan (ORCID: https://orcid.org/0000-0002-1140-740X)
- Mary Panaccio
- Kyle Hayes (ORCID: https://orcid.org/0000-0001-8203-4738)
- Amit Patel (ORCID: https://orcid.org/0000-0001-5737-4319)
- David Evans (ORCID: https://orcid.org/0000-0001-5217-0368)
- Priyanka P Shanbhag
Institutions
- Mallinckrodt (United States) (US)
Publication Details
- Journal
- Open Access Rheumatology Research and Reviews
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/oarrr.s538839
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mallinckrodt Pharmaceuticals